Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 19;12(1):122-128.
doi: 10.1093/emph/eoae016. eCollection 2024.

Germline mutation rate predicts cancer mortality across 37 vertebrate species

Affiliations

Germline mutation rate predicts cancer mortality across 37 vertebrate species

Stefania E Kapsetaki et al. Evol Med Public Health. .

Abstract

Background and objectives: Cancer develops across nearly every species. However, cancer occurs at unexpected and widely different rates throughout the animal kingdom. The reason for this variation in cancer susceptibility remains an area of intense investigation. Cancer evolves in part through the accumulation of mutations, and therefore, we hypothesized that germline mutation rates would be associated with cancer prevalence and mortality across species.

Methodology: We collected previously published data on germline mutation rate and cancer mortality data for 37 vertebrate species.

Results: Germline mutation rate was positively correlated with cancer mortality (P-value = 0.0008; R2 = 0.13). Controlling for species' average parental age, maximum longevity, adult body mass or domestication did not improve the model fit (the change (Δ) in Akaike Information Criterion (AIC) was less than 2). However, this model fit was better than a model controlling for species trophic level (ΔAIC > 2).

Conclusions and implications: The increased death rate from cancer in animals with increased germline mutation rates may suggest underlying hereditary cancer predisposition syndromes similar to those diagnosed in human patients. Species with higher germline mutation rates may benefit from close monitoring for tumors due to increased genetic risk for cancer development. Early diagnoses of cancer in these species may increase their chances of overall survival, especially for threatened and endangered species.

Keywords: animals; germ cell mutations; malignancy; tumor.

PubMed Disclaimer

Conflict of interest statement

J.D.S. is a co-founder and shareholder employed by Peel Therapeutics, Inc., and L.M.A. is a shareholder and consultant to Peel Therapeutics, Inc.

Figures

Figure 1.
Figure 1.
The average yearly germline mutation rate is positively correlated with the percentage of animals (among the total number of individuals per species examined at necropsy) that died from cancer. Each dot represents a species, and the size of the dot indicates the number of necropsies available for that species. Error bars show 95% confidence intervals. The regression line is phylogenetically controlled using the PGLS analysis. Species’ images are from PhyloPic (https://www.phylopic.org/).
Figure 2.
Figure 2.
The OU evolutionary model (A), rather than the BM (B) or EB model (C), best fits the species germline mutation rate data. Each point represents the reported log-likelihood at each generation of the MCMC fitting algorithm. The OU model indicates that the germline mutation rate is evolving towards an optimal value, and species evolved independently. The MCMC algorithm within the fitContinuousMCMC function generates samples of the parameter estimates from the posterior distribution. The likelihood is estimated at each generation of the algorithm to determine how well the parameter estimates fit the phylogenetic tree and the germline mutation rate data.

Similar articles

Cited by

  • The Elephant and the Spandrel.
    Compton ZT, Ågren JA, Marusyk A, Nedelcu AM. Compton ZT, et al. Evol Med Public Health. 2024 Aug 26;13(1):92-100. doi: 10.1093/emph/eoae019. eCollection 2025. Evol Med Public Health. 2024. PMID: 40276264 Free PMC article.
  • Cancer Prevalence across Vertebrates.
    Compton ZT, Mellon W, Harris VK, Rupp S, Mallo D, Kapsetaki SE, Wilmot M, Kennington R, Noble K, Baciu C, Ramirez LN, Peraza A, Martins B, Sudhakar S, Aksoy S, Furukawa G, Vincze O, Giraudeau M, Duke EG, Spiro S, Flach E, Davidson H, Li CI, Zehnder A, Graham TA, Troan BV, Harrison TM, Tollis M, Schiffman JD, Aktipis CA, Abegglen LM, Maley CC, Boddy AM. Compton ZT, et al. Cancer Discov. 2025 Jan 13;15(1):227-244. doi: 10.1158/2159-8290.CD-24-0573. Cancer Discov. 2025. PMID: 39445720 Free PMC article.
  • The relationship between diet, plasma glucose, and cancer prevalence across vertebrates.
    Kapsetaki SE, Basile AJ, Compton ZT, Rupp SM, Duke EG, Boddy AM, Harrison TM, Sweazea KL, Maley CC. Kapsetaki SE, et al. Nat Commun. 2025 Mar 12;16(1):2271. doi: 10.1038/s41467-025-57344-1. Nat Commun. 2025. PMID: 40074744 Free PMC article.

References

    1. Zhu L, Beichman AC, Harris K.. Reproductive life history may modulate selection on the germline mutation rate. bioRxiv 2023:2023.12.06.570457.
    1. Sung W, Ackerman MS, Miller SF. et al. Drift-barrier hypothesis and mutation-rate evolution. Proc Natl Acad Sci USA 2012;109:18488–92. - PMC - PubMed
    1. Lynch M, Ackerman MS, Gout J-F. et al. Genetic drift, selection and the evolution of the mutation rate. Nat Rev Genet 2016;17:704–14. - PubMed
    1. Zhang J, Pei R, Pang Z. et al. Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer. Breast Cancer Res Treat 2012;132:421–8. - PubMed
    1. Tomlinson IP, Novelli MR, Bodmer WF.. The mutation rate and cancer. Proc Natl Acad Sci USA 1996;93:14800–3. - PMC - PubMed

LinkOut - more resources